METEOR Trademark

Trademark Overview


On Tuesday, November 9, 2021, a trademark application was filed for METEOR with the United States Patent and Trademark Office. The USPTO has given the METEOR trademark a serial number of 79344258. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, April 16, 2024. This trademark is owned by Adaptate Biotherapeutics Limited. The METEOR trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of human disorders or diseases; antibodies and multi-specific antibodies, namely, colostral antibodies for medical purposes; biotechnological preparations for medical use; capsules sold empty for pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, pharmaceutical products for the prevention and treatment of cancer; injectable pharmaceuticals, namely, pharmaceutical products for the prevention and treatment of cancer; medical preparations and articles, namely, pharmaceutical products for the prevention and treatment of cancer; medicines for human purposes, namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical compositions namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical drugs namely, p...

biological preparations for use in industry and science; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses for scientific, laboratory, medical and medical research use; biological preparations for use in science; monoclonal antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; tagged monoclonal antibodies and multi-specific antibodies for scientific use; tagged monoclonal antibodies and multi-specific antibodies for laboratory use; proteins for binding antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; proteins for detecting antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; biochemical precursors for scientific purposes, namely, precursors for scientific, laboratory, medical and m...

biological research; clinical research in the field of pharmaceuticals; medical research; biomedical research services; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; conducting scientific clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; drug discovery services; information technology services for the pharmaceutical and healthcare industries; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; medical and pharmacological research services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; pharmaceuti...

General Information


Serial Number79344258
Word MarkMETEOR
Filing DateTuesday, November 9, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, April 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of human disorders or diseases; antibodies and multi-specific antibodies, namely, colostral antibodies for medical purposes; biotechnological preparations for medical use; capsules sold empty for pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, pharmaceutical products for the prevention and treatment of cancer; injectable pharmaceuticals, namely, pharmaceutical products for the prevention and treatment of cancer; medical preparations and articles, namely, pharmaceutical products for the prevention and treatment of cancer; medicines for human purposes, namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical compositions namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical drugs namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for medical purposes namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of anti-infective diseases; pharmaceutical preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of anti-infective diseases; pharmaceuticals preparations namely, pharmaceutical products for the prevention and treatment of cancer; biotechnological preparations for medical use in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; biotechnological preparations for medical use in relation to gamma delta t cells; biotechnological preparations for medical use in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to antibodies and multi- specific antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to gamma delta t cells antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to antibodies and multispecific antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to gamma delta t cells antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; drug delivery agents for controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to antibodies and multi-specific antibodies; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to gamma delta t cells; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry; drugs for medical purposes in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; drugs for medical purposes in relation to gamma delta t cells for treating human diseases and disorders; drugs for medical purposes in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceutical preparations in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; pharmaceutical preparations in relation to gamma delta t cells for treating human diseases and disorders; pharmaceutical preparations in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceutical preparations in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; pharmaceutical preparations in relation to gamma delta t cells for treating human diseases and disorders; pharmaceutical preparations in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceuticals in relation to antibodies and multispecific antibodies for treating human diseases and disorders; pharmaceuticals in relation to gamma delta t cells for treating human diseases and disorders; pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; none of the aforesaid goods in relation to agriculture, horticulture or forestry
Goods and Servicesbiological preparations for use in industry and science; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses for scientific, laboratory, medical and medical research use; biological preparations for use in science; monoclonal antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; tagged monoclonal antibodies and multi-specific antibodies for scientific use; tagged monoclonal antibodies and multi-specific antibodies for laboratory use; proteins for binding antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; proteins for detecting antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; biochemical precursors for scientific purposes, namely, precursors for scientific, laboratory, medical and medical research use; biochemical preparations for scientific purposes, namely, precursors for scientific, laboratory, medical and medical research; biochemical reagents used for non-medical purposes; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptides substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to antibodies and multi-specific antibodies for scientific, laboratory or medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to gamma delta t cells for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to gamma delta t cells for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptides substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; chemical compositions and preparations for use in science in relation to antibodies and multispecific antibodies; chemical compositions and preparations for use in science in relation to gamma delta t cells; chemical compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; chemical compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biological compositions and preparations for use in science in relation to antibodies and multi-specific antibodies; biological compositions and preparations for use in science in relation to gamma delta t cells; biological compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biological compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological precursors for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological precursors for scientific purposes in relation to gamma delta t cells; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological preparations for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological preparations for scientific purposes in relation to gamma delta t cells; biochemical and biological preparations for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological preparations for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological reagents used for non-medical purposes in relation to antibodies and multi-specific antibodies; biochemical and biological reagents used for non-medical purposes in relation to gamma delta t cells; biochemical and biological reagents used for non-medical purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological reagents used for non-medical purposes in relation to immunohistochemistry (IHC) and flow cytometry; none of the aforesaid goods in relation to agriculture, horticulture or forestry or assays for research purposes
Goods and Servicesbiological research; clinical research in the field of pharmaceuticals; medical research; biomedical research services; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; conducting scientific clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; drug discovery services; information technology services for the pharmaceutical and healthcare industries; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; medical and pharmacological research services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; pharmaceutical research services; providing information about the results of clinical trials for pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; research and development services in the field of antibodies and multi-specific antibodies; research and development services in the field of antibody technology; scientific research relating to medicines; research and development in the field of medical diagnostic preparations; biological research, clinical research and medical research in relation to antibodies and multi-specific antibodies; biological research, clinical research and medical research in relation to gamma delta t cells; biological research, clinical research and medical research in relation to immunohistochemistry (IHC) and flow cytometry; consultancy relating to pharmaceutical research and development in relation to antibodies and multi-specific antibodies; consultancy relating to pharmaceutical research and development in relation to gamma delta t cells; consultancy relating to pharmaceutical research and development in relation to immunohistochemistry (IHC) and flow cytometry; laboratory research services relating to pharmaceuticals in relation to antibodies and multi-specific antibodies; laboratory research services relating to pharmaceuticals in relation to gamma delta t cells; laboratory research services relating to pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry; medical and pharmacological research services in relation to antibodies and multi-specific antibodies; medical and pharmacological research services in relation to gamma delta t cells; medical and pharmacological research services in relation to immunohistochemistry (IHC) and flow cytometry; pharmaceutical research and development services in relation to antibodies and multi-specific antibodies; pharmaceutical research and development services in relation to gamma delta t cells; pharmaceutical research and development services in relation to immunohistochemistry (IHC) and flow cytometry; scientific and technological services in relation to scientific research in the field of antibodies and multi-specific antibodies; scientific and technological services in relation scientific research in the field of gamma delta t cells; scientific and technological services in relation scientific research in the field of immunohistochemistry (IHC) and flow cytometry; scientific research and development in relation to antibodies and multi-specific antibodies; scientific research and development in relation to gamma delta t cells; scientific research and development in relation to immunohistochemistry (IHC) and flow cytometry; information, advisory and consultancy services relating the aforesaid services, and none of the aforesaid services in relation to agriculture, horticulture or forestry

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGammaDelta Therapeutics Ltd
Party Type12 - New Owner Before Publication
Legal Entity Type77 - NOT AVAILABLE
AddressGB

Party NameGammaDelta Therapeutics Ltd
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLondon W26BD
GB

Party NameAdaptate Biotherapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, July 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, August 19, 2022ASSIGNED TO EXAMINER
Tuesday, August 23, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 24, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 30, 2022REFUSAL PROCESSED BY MPU
Friday, September 30, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 26, 2022REFUSAL PROCESSED BY IB
Saturday, February 4, 2023CHANGE OF OWNER RECEIVED FROM IB
Wednesday, March 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2023SUSPENSION LETTER WRITTEN
Thursday, April 20, 2023LETTER OF SUSPENSION E-MAILED
Thursday, April 20, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 18, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, April 16, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 31, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, November 25, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION